Market closedNon-fractional
Kamada/KMDA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Kamada
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Ticker
KMDA
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Rehovot, Israel
Employees
378
Website
www.kamada.com
Kamada Metrics
BasicAdvanced
$340M
Market cap
27.77
P/E ratio
$0.21
EPS
0.24
Beta
-
Dividend rate
Price and volume
Market cap
$340M
Beta
0.24
Financial strength
Current ratio
4.245
Quick ratio
1.976
Long term debt to equity
2.952
Total debt to equity
3.548
Management effectiveness
Return on equity (TTM)
5.90%
Valuation
Price to earnings (TTM)
27.768
Price to revenue (TTM)
2.078
Price to book
5.21
Price to tangible book (TTM)
11.9
Price to free cash flow (TTM)
402.985
Growth
Revenue change (TTM)
13.33%
Earnings per share change (TTM)
-515.35%
3-year revenue growth (CAGR)
6.20%
3-year earnings per share growth (CAGR)
-12.64%
What the Analysts think about Kamada
Analyst Ratings
Majority rating from 1 analysts.
Kamada Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$38M
3.57%
Net income
$2.3M
-54.00%
Profit margin
6.10%
-55.57%
Kamada Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.06
$0.09
$0.04
-
Expected
$0.02
$0.03
$0.05
$0.06
$0.06
Surprise
100.00%
100.00%
80.00%
-33.33%
-
Kamada News
AllArticlesVideos
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance
GlobeNewsWire·3 months ago
Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kamada stock?
Kamada (KMDA) has a market cap of $340M as of July 27, 2024.
What is the P/E ratio for Kamada stock?
The price to earnings (P/E) ratio for Kamada (KMDA) stock is 27.77 as of July 27, 2024.
Does Kamada stock pay dividends?
No, Kamada (KMDA) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Kamada dividend payment date?
Kamada (KMDA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kamada?
Kamada (KMDA) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Kamada stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.